🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Saketh R. Guntupalli

ORCID: 0000-0003-2570-6635
Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 4%percentile
0.870Author DataRank

Indexed papers

1in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Lifestyle intervention in ovarian cancer enhanced survival (LIVES) study (NRG/GOG0225): Recruitment, retention and baseline characteristics of a randomized trial of diet and physical activity in ovarian cancer survivors

Gynecologic Oncology(2023)10.1016/j.ygyno.2022.12.017
Top 23%
0.870DataRank
Top 23%21 citations

Tracy E. Crane, Austin Miller, Michael A. Gold, Matthew A. Powell, Kristin Bixel +15 more

Papers

Driven by 12 papers — median percentile 77. Top paper: “The presence of an endometrioid component does not alter the clinicopathologic profile or survival of patients with uterine serous cancer: A gynecologic oncology group (GOG/NRG) study of 934 women”.

The presence of an endometrioid component does not alter the clinicopathologic profile or survival of patients with uterine serous cancer: A gynecologic oncology group (GOG/NRG) study of 934 women

Gynecologic Oncology(2021)10.1016/j.ygyno.2020.12.040
N/A
0.941DataRank · unranked
26 citations

Wei Deng, Richard J. Zaino, Matthew A. Powell, Camille C. Gunderson, Casey Cosgrove +15 more

Lifestyle intervention in ovarian cancer enhanced survival (LIVES) study (NRG/GOG0225): Recruitment, retention and baseline characteristics of a randomized trial of diet and physical activity in ovarian cancer survivors

Gynecologic Oncology(2023)10.1016/j.ygyno.2022.12.017
Top 23%
0.870DataRank
Top 23%21 citations

Tracy E. Crane, Austin Miller, Michael A. Gold, Matthew A. Powell, Kristin Bixel +15 more

Mixed clear cell/endometrioid and clear cell/serous carcinoma of the uterus are clinicopathologically similar to pure clear cell carcinoma: An NRG Oncology/Gynecologic Oncology Group (GOG-210) study of 311 women

Gynecologic Oncology(2023)10.1016/j.ygyno.2023.08.005
N/A
0.360DataRank · unranked
10 citations

Wei Deng, Richard J. Zaino, Matthew A. Powell, Camille Gunderson Jackson, Casey Cosgrove +14 more

A phase II, randomized, double-blind study of the use of rucaparib vs. placebo maintenance therapy in metastatic and recurrent endometrial cancer

Gynecologic Oncology(2025)10.1016/j.ygyno.2025.07.008
N/A
0.208DataRank · unranked
3 citations

Ashley Haggerty, Stefan M. Gysler, Sarah E. Taylor, Kian Behbakht, Jill Alldredge +10 more

Combinatory EHMT and PARP inhibition induces an interferon response and a CD8 T cell-dependent tumor regression in PARP inhibitor-resistant models

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.02.23.529773
N/A
0DataRank · unranked
1 citations

Zachary L. Watson, Raquel Ortega, Elizabeth R. Woodruff, Kimberly R. Jordan, Ritsuko Iwanaga +10 more

Combining EHMT and PARP Inhibition: A Strategy to Diminish Therapy-Resistant Ovarian Cancer Tumor Growth while Stimulating Immune Activation

Molecular Cancer Therapeutics(2024)10.1158/1535-7163.mct-23-0613
N/A
0DataRank · unranked
12 citations

Zachary L. Watson, Raquel Ortega, Elizabeth R. Woodruff, Kimberly R. Jordan, Ritsuko Iwanaga +12 more

EHMT1/2 Inhibition Promotes Regression of Therapy-Resistant Ovarian Cancer Tumors in a CD8 T-cell–Dependent Manner

Molecular Cancer Research(2024)10.1158/1541-7786.mcr-24-0067
N/A
0DataRank · unranked
8 citations

Zachary L. Watson, Raquel Ortega, Elizabeth R. Woodruff, Kimberly R. Jordan, Ritsuko Iwanaga +13 more

Nonsteroidal Anti-inflammatory Drugs and Endometrial Carcinoma Mortality and Recurrence

UNC Libraries(2020)10.17615/4pe6-bb70
N/A
0DataRank · unranked
2 citations

Kay J. Park, David G. Mutch, Shashikant B. Lele, Louise A. Brinton, Shamshad Ali +14 more

Molecular Profiling and Tumor Biomarker Analysis of GOG281/LOGS: A Positive Late-Phase Trial of Trametinib for Recurrent/Persistent Low-Grade Serous Ovarian Carcinoma

Clinical Cancer Research(2025)10.1158/1078-0432.ccr-25-3042
N/A
0DataRank · unranked
2 citations

Austin Miller, Heather A. Lankes, Kwong‐Kwok Wong, William H. Rodgers, David Millan +20 more

Surgical-pathological findings in type 1 and 2 endometrial cancer: An NRG Oncology/Gynecologic Oncology Group study on GOG-210 protocol

UNC Libraries(2020)10.17615/5jcw-ca69
N/A
0DataRank · unranked
0 citations

David S. Miller, Steven Waggoner, Robert P. Edwards, Saketh R. Guntupalli, Matthew A. Powell +13 more

Beyond Sedlis—A novel histology-specific nomogram for predicting cervical cancer recurrence risk: An NRG/GOG ancillary analysis

Gynecologic Oncology(2021)10.1016/j.ygyno.2021.06.017
N/A
0DataRank · unranked
62 citations

Anna Beavis, Christopher Purdy, Anne F. Rositch, Akila N. Viswanathan, Aaron H. Wolfson +16 more

Loss of Claudin-4 Reduces DNA Damage Repair and Increases Sensitivity to PARP Inhibitors

Molecular Cancer Therapeutics(2022)10.1158/1535-7163.mct-21-0827
N/A
0DataRank · unranked
18 citations

Patricia Webb, Dana M. Davis, Heidi K. Baumgartner, Elizabeth R. Woodruff, Saketh R. Guntupalli +4 more